Learn how to comply with the EU AI Act when AI is used in GCP-critical eTMF contexts in part two of this series by Donatella Ballerini.
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
ON-DEMAND WEBINARS
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
Explore key challenges in accessing and preparing analytics-ready clinical data, how FAIR guiding principles can help maximize the value of clinical trial data, and the impact of innovative analytics.
Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable.
During this panel discussion, key opinion leaders from biopharma and academia explore ways to bridge the knowledge gap that exists between these groups and foster research collaborations to help advance the use of digital endpoints in clinical development.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-995338664 doctor data]( "The Stakeholder Benefits Of EHR eSource In Clinical Trials")
The Stakeholder Benefits Of EHR eSource In Clinical TrialsDiscover the transformative power of EHR eSource integration through the eyes of a clinical research coordinator and project director in an adaptive platform trial.
-
![GettyImages-1195510533 diverse patients]( "Achieving Person-Centricity In Clinical Trial Recruitment")
Achieving Person-Centricity In Clinical Trial RecruitmentClinical trial enrollment remains a major bottleneck in drug development, but consumer-centric innovations could present a solution to enhance every stage of clinical trial enrollment.
-
![GettyImages-1321088893 ps]( "To Counter Bias, Counterbalance")
To Counter Bias, CounterbalanceIt’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.
-
![GettyImages-1216142675 healthcare data]( "Lessons From China And The United States On The Use Of RWE In Regulatory Submissions")
Lessons From China And The United States On The Use Of RWE In Regulatory SubmissionsRead along as authors share their most significant lessons, offering guidance on how to harness the full potential of RWE to drive innovation and efficiency in drug development.
-
![GettyImages-1333253892-doctor-legal-regulatory]( "Simplifying The Regulatory Submission Process With A Modern CTMS")
Simplifying The Regulatory Submission Process With A Modern CTMSWorking in collaboration with industry representatives, explore the value that pulling the regulatory submission process into a modern Clinical Trial Management System (CTMS) could have.
-
![Winning strategy efficiency innovation-+GettyImages-1359225856]( "What Everest Group's RTSM Recognition Means For The Industry")
What Everest Group's RTSM Recognition Means For The IndustryRTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
![GettyImages-1257716223 fda guide]( "FDA Guidance Has Implications For EDC And EHR eSource Capabilities")
FDA Guidance Has Implications For EDC And EHR eSource CapabilitiesGain insight from an eSource study observing digitally received data as far back as 2007 to just before initial guidance was released by the U.S. FDA in 2013.
-
![data analytics team meeting-GettyImages-2166193783]( "Paperless Online Remote Source Document Verification")
Paperless Online Remote Source Document VerificationLearn how Clinical Trial Organizations, Monitoring Teams and Clinical Sites can benefit from the way Judi transforms rSDV from a logistical hurdle into a strategic asset.
-
![alternative way, changing plans, flexibility-GettyImages-2151843291]( "Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders")
Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate LeadersDigital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "EDC Powers End-To-End Data Management In Pharma-Sponsored Trials")
EDC Powers End-To-End Data Management In Pharma-Sponsored TrialsAs clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders
- 01.22.26 -- The Role Of Open Source In Powering CDISC 360i
- 01.15.26 -- Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity